Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Current Deferred Revenue (2016 - 2025)

Alkermes (ALKS) has disclosed Current Deferred Revenue for 15 consecutive years, with $578000.0 as the latest value for Q2 2025.

  • On a quarterly basis, Current Deferred Revenue fell 82.54% to $578000.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $578000.0, a 82.54% decrease, with the full-year FY2024 number at $1.2 million, down 73.84% from a year prior.
  • Current Deferred Revenue was $578000.0 for Q2 2025 at Alkermes, down from $1.6 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $20.8 million in Q2 2021 to a low of $578000.0 in Q2 2025.
  • A 5-year average of $7.9 million and a median of $4.8 million in 2023 define the central range for Current Deferred Revenue.
  • Peak YoY movement for Current Deferred Revenue: skyrocketed 137.35% in 2021, then plummeted 82.54% in 2025.
  • Alkermes' Current Deferred Revenue stood at $17.8 million in 2021, then crashed by 39.98% to $10.7 million in 2022, then crashed by 55.38% to $4.8 million in 2023, then tumbled by 73.84% to $1.2 million in 2024, then tumbled by 53.72% to $578000.0 in 2025.
  • Per Business Quant, the three most recent readings for ALKS's Current Deferred Revenue are $578000.0 (Q2 2025), $1.6 million (Q1 2025), and $1.2 million (Q4 2024).